245 related articles for article (PubMed ID: 37439101)
1. Oral delivery of biomacromolecules by overcoming biological barriers in the gastrointestinal tract: an update.
Liu S; Wen X; Zhang X; Mao S
Expert Opin Drug Deliv; 2023; 20(10):1333-1347. PubMed ID: 37439101
[TBL] [Abstract][Full Text] [Related]
2. Nanocarriers transport across the gastrointestinal barriers: The contribution to oral bioavailability via blood circulation and lymphatic pathway.
Wang D; Jiang Q; Dong Z; Meng T; Hu F; Wang J; Yuan H
Adv Drug Deliv Rev; 2023 Dec; 203():115130. PubMed ID: 37913890
[TBL] [Abstract][Full Text] [Related]
3. Strategies and industrial perspectives to improve oral absorption of biological macromolecules.
Liu C; Kou Y; Zhang X; Cheng H; Chen X; Mao S
Expert Opin Drug Deliv; 2018 Mar; 15(3):223-233. PubMed ID: 29111841
[TBL] [Abstract][Full Text] [Related]
4. Polymeric nanoparticle drug delivery technologies for oral delivery applications.
Pridgen EM; Alexis F; Farokhzad OC
Expert Opin Drug Deliv; 2015; 12(9):1459-73. PubMed ID: 25813361
[TBL] [Abstract][Full Text] [Related]
5. Oral drug delivery with polymeric nanoparticles: the gastrointestinal mucus barriers.
Ensign LM; Cone R; Hanes J
Adv Drug Deliv Rev; 2012 May; 64(6):557-70. PubMed ID: 22212900
[TBL] [Abstract][Full Text] [Related]
6. Overcoming multiple gastrointestinal barriers by bilayer modified hollow mesoporous silica nanocarriers.
Wang Y; Zhao Y; Cui Y; Zhao Q; Zhang Q; Musetti S; Kinghorn KA; Wang S
Acta Biomater; 2018 Jan; 65():405-416. PubMed ID: 29037897
[TBL] [Abstract][Full Text] [Related]
7. Engineering strategies to enhance nanoparticle-mediated oral delivery.
Yamanaka YJ; Leong KW
J Biomater Sci Polym Ed; 2008; 19(12):1549-70. PubMed ID: 19017470
[TBL] [Abstract][Full Text] [Related]
8. Polyaminoacid-based nanocarriers: a review of the latest candidates for oral drug delivery.
Robla S; Alonso MJ; Csaba NS
Expert Opin Drug Deliv; 2020 Aug; 17(8):1081-1092. PubMed ID: 32478584
[TBL] [Abstract][Full Text] [Related]
9. Biocompatible smart micro/nanorobots for active gastrointestinal tract drug delivery.
Zhang B; Zhu L; Pan H; Cai L
Expert Opin Drug Deliv; 2023; 20(10):1427-1441. PubMed ID: 37840310
[TBL] [Abstract][Full Text] [Related]
10. Self-emulsifying drug delivery systems in oral (poly)peptide drug delivery.
Leonaviciute G; Bernkop-Schnürch A
Expert Opin Drug Deliv; 2015; 12(11):1703-16. PubMed ID: 26477549
[TBL] [Abstract][Full Text] [Related]
11. Promising strategies for improving oral bioavailability of poor water-soluble drugs.
Rocha B; de Morais LA; Viana MC; Carneiro G
Expert Opin Drug Discov; 2023 Jun; 18(6):615-627. PubMed ID: 37157841
[TBL] [Abstract][Full Text] [Related]
12. Oral peptide delivery: Translational challenges due to physiological effects.
Tyagi P; Pechenov S; Anand Subramony J
J Control Release; 2018 Oct; 287():167-176. PubMed ID: 30145135
[TBL] [Abstract][Full Text] [Related]
13. Recent progress of micro/nanomotors to overcome physiological barriers in the gastrointestinal tract.
Zhang S; Zhu C; Huang W; Liu H; Yang M; Zeng X; Zhang Z; Liu J; Shi J; Hu Y; Shi X; Wang ZH
J Control Release; 2023 Aug; 360():514-527. PubMed ID: 37429360
[TBL] [Abstract][Full Text] [Related]
14. Oral targeted drug delivery to post-gastrointestinal sites.
Han R; He H; Lu Y; Lu H; Shen S; Wu W
J Control Release; 2024 Jun; 370():256-276. PubMed ID: 38679163
[TBL] [Abstract][Full Text] [Related]
15. Enhanced oral bioavailability from food protein nanoparticles: A mini review.
Zhang T; Li L; Chunta S; Wu W; Chen Z; Lu Y
J Control Release; 2023 Feb; 354():146-154. PubMed ID: 36566844
[TBL] [Abstract][Full Text] [Related]
16. The Influence of Nanoparticle Properties on Oral Bioavailability of Drugs.
Wang Y; Pi C; Feng X; Hou Y; Zhao L; Wei Y
Int J Nanomedicine; 2020; 15():6295-6310. PubMed ID: 32943863
[TBL] [Abstract][Full Text] [Related]
17. A review of advanced oral drug delivery technologies facilitating the protection and absorption of protein and peptide molecules.
Choonara BF; Choonara YE; Kumar P; Bijukumar D; du Toit LC; Pillay V
Biotechnol Adv; 2014 Nov; 32(7):1269-1282. PubMed ID: 25099657
[TBL] [Abstract][Full Text] [Related]
18. Targeting the intestinal lymphatic system: a versatile path for enhanced oral bioavailability of drugs.
Managuli RS; Raut SY; Reddy MS; Mutalik S
Expert Opin Drug Deliv; 2018 Aug; 15(8):787-804. PubMed ID: 30025212
[TBL] [Abstract][Full Text] [Related]
19. Strategies toward the improved oral delivery of insulin nanoparticles via gastrointestinal uptake and translocation.
Woitiski CB; Carvalho RA; Ribeiro AJ; Neufeld RJ; Veiga F
BioDrugs; 2008; 22(4):223-37. PubMed ID: 18611065
[TBL] [Abstract][Full Text] [Related]
20. Improving oral drug bioavailability with polycations?
Schulz JD; Gauthier MA; Leroux JC
Eur J Pharm Biopharm; 2015 Nov; 97(Pt B):427-37. PubMed ID: 26614561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
